BridgeBio Pharma Inc. (BBIO) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Join SI Premium – FREE
BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q3 EPS of ($0.95), $0.07 worse than the analyst estimate of ($0.88). Revenue for the quarter came in at $120.7 million versus the consensus estimate of $107.62 million.
For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Over 6 million children enrolled in Trump Accounts program
- Richmond Fed Manf. Index (Jun) 4 vs 8 Expected
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
